CCHR Demands Investigation Into Link Between Antidepressants And Teen Suicides
According to Psychology Today, psychiatrists have known for years about something called ‘roll back’ which is when antidepressants have an activating effect that can give depressed patients the energy to follow through on suicidal impulses.
Clearwater, United States – July 28, 2016 /PressCable/ —
The Citizens Commission on Human Rights (CCHR), a non-profit mental health watchdog organization dedicated to the eradication of abuses committed under the guise of mental health, is demanding an investigation into the link between antidepressants and teen suicides.
According to the Florida Suicide Prevention Coalition, suicide is the 3rd leading cause of death for teenagers in Florida [i] and the Journal of the American Medical Association (JAMA) – Psychiatryalso reported in a March 2013 study on the topic of teen suicide that there is a link between suicide and psychiatric treatment.[ii]
The JAMA study reported that the teens were put on psychiatric drugs before they started having suicidal thoughts or making suicide attempts and the drugs did nothing to prevent it. In fact, their own study showed 55% -77% of the teens that developed suicidal behavior did so after being treated with psychiatric medication.
“Tragically, many parents of teenagers are unaware of the connection between psychiatric drugs and teen suicide and so in an effort to help their child they unfortunately may end up with their teen in roll back,” said Diane Stein, President of CCHR Florida.
Psychology Today reports, “For years psychiatrists have known about something called ‘roll back.’ Antidepressants sometimes have an activating effect that can give depressed patients the energy to follow through on suicidal impulses…”
In the Psychology Today article Dr. Robert Muller addresses the suicide of Brennan McCartney, described as “fun-loving and good-natured” by family and friends. Brennan went to the doctor in November of 2010 with a chest cold, but came home with a prescription for Cipralex, an antidepressant drug. His parents “were astonished” as they had seen no sign of depression in their son. According to a close family friend, Brennan was not a boy to hide his emotions, and “everyone around him knew whether Brennan was happy or sad.” Yet four days after beginning treatment with Cipralex, Brennan purchased a rope and hung himself.[iii]
“CCHR is demanding that the link between antidepressants and teen suicide be investigated and made known so that lives can be saved and this will be the issue we push during Suicide Prevention Awareness Month this coming September,” said Diane Stein.
To learn more, please call 727-442-8820 or visit www.cchrflorida.org for more information.
About CCHR:
Initially established by the Church of Scientology and renowned psychiatrist Dr. Thomas Szasz in 1969, CCHR’s mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections.
It was L. Ron Hubbard, the founder of Scientology, who brought the terror of psychiatric imprisonment to the notice of the world. In March 1969, he said, “Thousands and thousands are seized without process of law, every week, over the ‘free world’ tortured, castrated, killed. All in the name of ‘mental health.’”
After discovering that 55 percent of foster children in Florida had been prescribed powerful mind-altering psychotropic drugs, CCHR documented the abuse to the health department, which initiated changes that led to a 75 percent reduction in prescriptions for children under six.
Considered a potentially abusive, marketing tool for psychiatrists, CCHR Florida led the charge that got “Teen Screen”, mental health screening of school children, banned from Pinellas County schools in 2005.
[i] [ii] [iii] http://www.cchrflorida.org/cchr-demands-investigat…
For more information, please visit http://www.cchrflorida.org/
Contact Info:
Name: Diane Stein
Email: publicaffairs@cchrflorida.org
Organization: Citizens Commission on Human Rights of Florida
Address: 109 N. Fort Harrison Ave
Phone: 727-442-8820
Release ID: 125446